Guardant Health Inc (NASDAQ:GH) has a beta value of 0.86 and has seen 1.84 million shares traded in the last trading session. The company, currently valued at $2.12B, closed the last trade at $17.45 per share which meant it lost -$0.29 on the day or -1.63% during that session. The GH stock price is -135.3% off its 52-week high price of $41.06 and -1.15% below the 52-week low of $17.65. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.67 million shares traded. The 3-month trading volume is 1.64 million shares.
Guardant Health Inc (NASDAQ:GH) trade information
Sporting -1.63% in the red in last session, the stock has traded in the red over the last five days, when the GH stock price touched $17.45 or saw a rise of 10.33%. Year-to-date, Guardant Health Inc shares have moved -35.49%, while the 5-day performance has seen it change -8.11%. Over the past 30 days, the shares of Guardant Health Inc (NASDAQ:GH) have changed -21.15%. Short interest in the company has seen 7.05 million shares shorted with days to cover at 3.73.
Guardant Health Inc (GH) estimates and forecasts
Figures show that Guardant Health Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -40.91% over the past 6 months, with this year growth rate of 19.63%, compared to 13.60% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 36.20% and -19.40% for the next quarter. Revenue growth from the last financial year stood is estimated to be 17.80%.
18 analysts offering their estimates for the company have set an average revenue estimate of $150.68 million for the current quarter. 18 have an estimated revenue figure of $161.22 million for the next quarter concluding in Jun 2024. Year-ago sales stood $128.71 million and $137.15 million respectively for this quarter and the next, and analysts expect sales will grow by 17.10% for the current quarter and 17.60% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -8.88% over the past 5 years. Earnings growth for 2024 is a modest 23.68% while over the next 5 years, the company’s earnings are expected to increase by 27.80%.
GH Dividends
Guardant Health Inc is expected to release its next earnings report between May 07 and May 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Insiders own 4.15% of the company shares, while shares held by institutions stand at 92.40% with a share float percentage of 96.40%. Investors are also buoyed by the number of investors in a company, with Guardant Health Inc having a total of 413 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc with over 10.8 million shares worth more than $386.76 million. As of Jun 29, 2023, Vanguard Group Inc held 9.18% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 9.68 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $346.46 million and represent 8.22% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Mutual Fund Ser Tr-Eventide Gilead Fund. As of Jun 29, 2023, the former fund manager holds about 2.90% shares in the company for having 3.42 million shares of worth $122.31 million while later fund manager owns 2.96 million shares of worth $106.06 million as of Jun 29, 2023, which makes it owner of about 2.52% of company’s outstanding stock.
